Generation bio appoints ron cooper to its board of directors

Cambridge, mass., feb. 18, 2021 (globe newswire) -- generation bio co. (nasdaq: gbio), an innovative genetic medicines company creating a new class of gene therapy, announced today that ron cooper has been appointed to its board of directors. the appointment is effective march 1, 2021.

GBIO Ratings Summary

GBIO Quant Ranking